LONDON (Reuters) - A new two-in-one diabetes pill from AstraZeneca has been approved by U.S. regulators, the British drugmaker said on Thursday.
from
from
الخميس، 30 أكتوبر 2014
AstraZeneca wins U.S. approval for two-in-one diabetes pill
الاشتراك في:
تعليقات الرسالة
(
Atom
)
يتم التشغيل بواسطة Blogger.
أرشيف المدونة الإلكترونية
-
▼
2014
(9481)
-
▼
أكتوبر
(1502)
- China's October factory growth unexpectedly hits f...
- Congo crowd kills man, eats him after militant mas...
- India considers ban on e-cigarettes, sale of singl...
- Sony reports narrower second-quarter loss than est...
- UPDATE 1-Sony reports narrower Q2 loss than estima...
- Italy - Factors to watch on October 31
- Starbucks Americas sales disappoint on softer traffic
- GLOBAL MARKETS-Japan shares soar, yen skids after ...
- BRIEF-Pros Holdings launches squeeze-out for outst...
- Indonesia's new energy chief seeks to shore up reg...
- UPDATE 4-Starbucks Americas sales disappoint on so...
- Weyerhaeuser reports higher third-quarter profit
- UPDATE 1-Samsung Elec seeks China comeback with fi...
- TABLE-Panasonic -2014/15 group forecast(SEC)
- TABLE-Panasonic -6-MTH group results (SEC)
- Nikkei jumps to 7-year high after BOJ's policy sho...
- UK Stocks-Factors to watch on Friday Oct 31
- Starbucks Americas sales disappoint on softer traffic
- Clippers launch new era under Balmer with scrappy win
- Thousands denounce HSBC board member's likening of...
- BOJ shocks markets with more easing as inflation s...
- JAL worried about potential impact of Ebola on tra...
- HTC forecasts higher fourth-quarter sales; above m...
- UPDATE 1-RBS sets aside $639 million to settle for...
- Swiss stocks - Factors to watch on Oct 31
- RBS sets aside $639 million to settle forex probes
- UPDATE 1-Thousands denounce HSBC board member's li...
- Wal-Mart to expand discounts as retail price war h...
- Gray wolf reported at Grand Canyon for first time ...
- Fed's Williams: inflation targets work, but room f...
- UK Stocks-Factors to watch on Friday Oct 31
- Europe Factors to Watch-Shares set to track Tokyo'...
- BRIEF-Lonza CEO says has no divestment plans at pr...
- UPDATE 1-South Korea unveils plans to grow as glob...
- UPDATE 1-AB InBev profit capped by weak U.S., stag...
- European Factors to Watch on Friday Oct 31
- TABLE-Makita -6-MTH group results (SEC)
- AB InBev profit rise capped by U.S. and Brazil
- Nikkei closes at highest since 2007 as BOJ unexpec...
- Thousands denounce HSBC board member's likening of...
- Japan's wireless carriers told to unlock phones st...
- Sony reports narrower second-quarter loss than est...
- TABLE-Komatsu -2014/15 parent forecast
- Kurds' battle for Kobani unites a people divided b...
- TABLE-Komatsu -6-MTH group results (SEC)
- TABLE-Komatsu -2014/15 group forecast(SEC)
- Thousands denounce HSBC board member's likening of...
- TABLE-TDK -6-MTH group results (SEC)
- TABLE-Sony -6-MTH group results (SEC)
- South Korea unveils plans to grow as global yuan hub
- Sony reports narrower second-quarter loss than est...
- Nikkei jumps to 7-year high after BOJ shocks by ea...
- BRIEF-Auriant mining acquires 70 pct of Kara-Beldyr
- Taiwan's Ching Fu says wins bid to build minesweep...
- GTECH reduces bridge loan credit facility for IGT ...
- Britain's Fraud Office launches probe into Tesco a...
- European Factors to Watch-Results to help euro zon...
- UPDATE 1-Accor goes digital to combat online rivals
- Brazil's Bradesco cuts loan book growth, ups reven...
- UPDATE 1-UK Stocks-Factors to watch on Thursday Oc...
- REFILE-Sony changes head of troubled mobile division
- UPDATE 1-Barclays sets aside $800 mln for FX probe...
- Brazil's Bradesco beats profit estimates as revenu...
- BRIEF-Shell Q3 CCS earnings $5.3 bln
- BRIEF-Pharming Group 9-month revenues from product...
- Israeli police kill Palestinian suspected of shoot...
- AstraZeneca wins U.S. approval for two-in-one diab...
- France says conditions still not met to deliver wa...
- Sweden to officially recognize Palestinian state o...
- UPDATE 1-Linde cuts outlook on China, Brazil impai...
- Barclays sets aside $800 mln for FX probe, Q3 prof...
- AstraZeneca wins U.S. approval for two-in-one diab...
- UPDATE 1-Norway's Schibsted results beat forecasts...
- TABLE-Kyocera -6-MTH group results (SEC)
- BRIEF-Medigene's licensee enters promotion agreeme...
- UK Stocks-Factors to watch on Thursday Oct 30
- GE in talks to sell stake in South Korea finance J...
- Israeli police kill Palestinian suspected of shoot...
- Holcim says not to form joint organisation with Ce...
- U.S. drone strike kills five militants in Pakistan
- European Factors to Watch-Flat start eyed, earning...
- TABLE-Kirin HD -9-MTH group results
- TABLE-Fuji Film Holdings -6-MTH group results (SEC)
- UPDATE 1-Ukraine gas supplies in doubt as Russia s...
- U.S. drone strike kills five militants in Pakistan
- China's Baidu says mobile investment a priority as...
- China's Baidu says mobile investment a priority as...
- UPDATE 2-China's Baidu says mobile investment a pr...
- PRESS DIGEST- New York Times business news - Oct 30
- Romania's taxing problem will still trouble incomi...
- Nikkei climbs on U.S. economy optimism; Nintendo s...
- UPDATE 1-Market Chatter-Corporate finance press di...
- Rent squeeze points to frailty of Spain's retail b...
- UPDATE 2-China's Baidu says mobile investment a pr...
- TABLE-NEC -6-MTH group results
- PRESS DIGEST- New York Times business news - Oct 30
- Indian film-maker hopes to take gay issues out of ...
- Xiaomi moves into third place in global smartphone...
- Microsoft launches wearable fitness device for $199
- China probes Uighur mayor of restive Xinjiang city...
-
▼
أكتوبر
(1502)
111
111
ليست هناك تعليقات :
إرسال تعليق